ENTITY
Mayne Pharma

Mayne Pharma (MYX AU)

31
Analysis
Health CareAustralia
Mayne Pharma Group Ltd. develops and manufactures oral pharmaceuticals. The Company produces branded generics, specialty generics, and active pharmaceutical ingredients.
more
Refresh
bearishBlackmores Ltd
24 Mar 2017 23:18

Financial Forensics - The Short-Seller's Indispensable Tool-Kit

Financial forensics remains an indispensable part of the short-seller's tool-kit. In this report, Evidente updates and expands its analysis of...

Logo
355 Views
Share
21 Feb 2017 16:05

Australian Growth Stocks: The Big Short (Still)

Four months ago, Evidente published a post suggesting that Australian growth stocks were over-priced The Big Short: Australian Growth Stocks and...

Logo
397 Views
Share
bearishMylan NV
14 Nov 2016 11:55

Generic Drug Antitrust Inquiry: A Primer

Recent news stories reporting looming criminal antitrust charges against certain generic drug companies (and possibly executives) are wighing on...

Share
03 Nov 2016 22:15

Re-Visiting the Big Short: Australian Growth Stocks

Last month, Evidente documented that the valuation dispersion between value and growth stocks was without precedent; the median book multiple of...

Logo
210 Views
Share
01 Oct 2016 22:02

The Big Short: Australian Growth Stocks

In a recent update to investors, founder and CEO of Platinum Asset Management, Mr Kerr Nielson, cited that global conditions had been challenging...

Logo
228 Views
Share
x